Cancer hallmarks in induced pluripotent cells: New insights
- 23 August 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 225 (2), 390-393
- https://doi.org/10.1002/jcp.22280
Abstract
Studies are beginning to emerge that demonstrate intriguing differences between human‐induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs). Here, we investigated the expression of key members of the Nodal embryonic signaling pathway, critical to the maintenance of pluripotency in hESCs. Western blot and real‐time RT‐PCR analyses reveal slightly lower levels of Nodal (a TGF‐β family member) and Cripto‐1 (Nodal's co‐receptor) and a dramatic decrease in Lefty (Nodal's inhibitor and TGF‐β family member) in hiPSCs compared with hESCs. The noteworthy drop in hiPSC's Lefty expression correlated with an increase in the methylation of Lefty B CpG island. Based on these findings, we addressed a more fundamental question related to the consequences of epigenetically reprogramming hiPSCs, especially with respect to maintaining a stable ESC phenotype. A global comparative analysis of 365 microRNAs (miRs) in two hiPSC versus four hESC lines ultimately identified 10 highly expressed miRs in hiPCSs with >10‐fold difference, which have been shown to be cancer related. These data demonstrate cancer hallmarks expressed by hiPSCs, which will require further assessment for their impact on future therapies. J. Cell. Physiol. 225: 390–393, 2010.Keywords
This publication has 20 references indexed in Scilit:
- Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early SenescenceThe International Journal of Cell Cloning, 2010
- Restricted ethnic diversity in human embryonic stem cell linesNature Methods, 2010
- Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblastsNature Genetics, 2009
- Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression SignaturesCell Stem Cell, 2009
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survivalInternational Journal of Cancer, 2009
- Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative MedicineThe International Journal of Cell Cloning, 2009
- Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression ProfileNeoplasia, 2009
- MicroRNA profile analysis of human prostate cancersCancer Gene Therapy, 2008
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisProceedings of the National Academy of Sciences, 2008
- c-Myc Is Dispensable for Direct Reprogramming of Mouse FibroblastsCell Stem Cell, 2008